Roche, Genentech to Develop $700M Pharmaceutical Manufacturing Facility in Holly Springs, North Carolina
61HOLLY SPRINGS, N.C. — Genentech, a Bay Area-based biotech firm and member of the Switzerland-based Roche Group, plans to develop a $700 million pharmaceutical manufacturing facility in Holly Springs, approximately 20 miles southwest of Raleigh. The new …